Pramlintide Acetate...

Pramlintide Acetate Hydrate/ 196078-30-5
Pramlintide Acetate Hydrate/ 196078-30-5
Pramlintide Acetate Hydrate/ 196078-30-5
Pramlintide Acetate Hydrate/ 196078-30-5
Pramlintide Acetate Hydrate/ 196078-30-5

Pramlintide Acetate Hydrate/ 196078-30-5

Min.Order / FOB Price:Get Latest Price

1 Gram

FOB Price: USD 15.0000

  • Min.Order :1 Gram
  • Purity: 99%
  • Payment Terms : T/T,Other

Keywords

Peptides Pharmaceutical Intermediate Chemical

Quick Details

  • Appearance:White Powder
  • Application:bodybuilding pharmaceutical material, Steroid hormone, Anabolin. As a male hormone and anabolic hormones.
  • PackAge:Packaging can be according to customer
  • ProductionCapacity:10000|Metric Ton|Day
  • Storage:Keep it under seal in cool and dark place
  • Transportation:FEDEX DHL TNT UPS EUB

Superiority:

This is Allen  from Zhengzhou Filter Biotechnology Co.,Ltd.We are the professional supplier of peptide products in China over 10 years. we have Professional Lab to confirm the Quality and Serive for all clients in long-term run cooperation.
Our Company as a Pharmaceutical Raw Material Manufacturer specialize in R&D the New Drugs and Producing the Generic Medicine:

Amino Acids&Vitamins
Pharmaceutical Polypeptide,
Comestic Polypeptide,
Veterinary Peptide and 
Pharmaceutical APIs.
Due to of the high quality and good service, They have been exported more than 30 countries. 
Sincerely hope to have a chance to cooperate with you

Details:

Description
 
1.Product Name : Pramlintide Acetate/Pramlintide acetate hydrate/ 196078-30-5
2.Appearance : White Powder 

3.Specification :95%
4.Introduction :
Pramlintide (Symlin) is a relatively new injectable drug for  diabetes (both type 1 and 2), developed by Amylin  Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca )Pramlintide is sold as an acetate salt.
Pramlintide is an analogue of  amylin ,a small peptide hormone that is released into the bloodstream by the β-cells of the pancreas along with insulin, after a meal.Like insulin, amylin is completely absent in individuals with Type I diabetes.
Reduction in glycated hemoglobin and weight loss have been shown in insulin-treated patients with type 2 diabetes taking pramlintide as an adjunctive therapy.
By augmenting endogenous amylin, pramlintide aids in the cellular absorption and regulation of blood glucose by slowing gastric emptying, promoting satiety via hypothalamic receptors (different receptors than for GLP-1), and inhibiting inappropriate secretion of glucagon, a catabolic hormone that opposes the effects of insulin and amylin. Pramlintide also has effects in raising the acute first-phase insulin response threshold following a meal.

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View